Asterias Biotherapeutics, Inc.;The Regents of The University of California
发明人:
Edward D. Wirth, III,Stanley T. Carmichael,Irene Lorenzo Llorente,Nathan C. Manley
申请号:
US15753135
公开号:
US20180236004A1
申请日:
2016.08.15
申请国别(地区):
US
年份:
2018
代理人:
摘要:
In various embodiments methods and compositions for improving a recovery of a subject after a cerebral ischemic injury, such as white matter stroke are provided. In various embodiments, the methods involve administering stem cell-derived oligodendrocyte progenitor cells into or directly adjacent to the infarct core in the brain of the subject.